WallStreetZenWallStreetZen

NASDAQ: CTXR
Citius Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CTXR

Based on 2 analysts offering 12 month price targets for Citius Pharmaceuticals Inc

Min Forecast
$9.00+1,081.1%
Avg Forecast
$54.50+7,052.23%
Max Forecast
$100.00+13,023.36%

Should I buy or sell CTXR stock?

Based on 2 analysts offering ratings for Citius Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CTXR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CTXR as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their CTXR stock forecasts and price targets.

CTXR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-18
lockedlocked$00.00+00.00%2024-11-12

1 of 1

Forecast return on equity

Is CTXR forecast to generate an efficient return?

Company
N/A
Industry
146.26%
Market
80.85%

Forecast return on assets

Is CTXR forecast to generate an efficient return on assets?

Company
N/A
Industry
36.38%

CTXR earnings per share forecast

What is CTXR's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$4.04
Avg 2 year Forecast
-$0.20

CTXR revenue forecast

What is CTXR's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$38.0M

CTXR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CTXR$0.76$54.50+7,052.23%Strong Buy
MTVA$0.78$12.00+1,438.46%Buy
GNPX$0.28N/AN/A
QNRX$6.58N/AN/A
INDP$0.47$5.00+963.83%Strong Buy
View Top Biotech Stocks

Citius Pharmaceuticals Stock Forecast FAQ

Is Citius Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CTXR) stock is to Strong Buy CTXR stock.

Out of 2 analysts, 1 (50%) are recommending CTXR as a Strong Buy, 1 (50%) are recommending CTXR as a Buy, 0 (0%) are recommending CTXR as a Hold, 0 (0%) are recommending CTXR as a Sell, and 0 (0%) are recommending CTXR as a Strong Sell.

If you're new to stock investing, here's how to buy Citius Pharmaceuticals stock.

What is CTXR's earnings growth forecast for 2025-2026?

(NASDAQ: CTXR) Citius Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Citius Pharmaceuticals's earnings in 2025 is -$40,723,212.On average, 1 Wall Street analyst forecast CTXR's earnings for 2025 to be -$34,717,469, with the lowest CTXR earnings forecast at -$34,717,469, and the highest CTXR earnings forecast at -$34,717,469.

In 2026, CTXR is forecast to generate -$1,718,687 in earnings, with the lowest earnings forecast at -$1,718,687 and the highest earnings forecast at -$1,718,687.

What is CTXR's revenue growth forecast for 2026-2026?

(NASDAQ: CTXR) Citius Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.

Citius Pharmaceuticals's revenue in 2025 is $0.

In 2026, CTXR is forecast to generate $326,550,454 in revenue, with the lowest revenue forecast at $326,550,454 and the highest revenue forecast at $326,550,454.

What is CTXR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CTXR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 36.38%.

What is CTXR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CTXR price target, the average CTXR price target is $54.50, with the highest CTXR stock price forecast at $100.00 and the lowest CTXR stock price forecast at $9.00.

On average, Wall Street analysts predict that Citius Pharmaceuticals's share price could reach $54.50 by Feb 18, 2026. The average Citius Pharmaceuticals stock price prediction forecasts a potential upside of 7,052.23% from the current CTXR share price of $0.76.

What is CTXR's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: CTXR) Citius Pharmaceuticals's current Earnings Per Share (EPS) is -$5.77. On average, analysts forecast that CTXR's EPS will be -$4.04 for 2025, with the lowest EPS forecast at -$4.04, and the highest EPS forecast at -$4.04. In 2026, CTXR's EPS is forecast to hit -$0.20 (min: -$0.20, max: -$0.20).

What is CTXR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CTXR) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.